Search
for
Sort by
Research 511–540 of 1000+
- Skin and Scalp Health Benefits of a Specific Botanical Extract Blend: Results from a Double-Blind Placebo-Controlled Study in Urban Outdoor Workers
- Systemic Lupus Erythematosus: What Every Clinician Needs to Know
- The Multisystem Impact of Long COVID: A Comprehensive Review
- ESCITALOPRAM
- The Rotterdam Study: objectives and design update
- An assessment of the nutritional status of internally displaced school children in the West and Littoral Regions of Cameroon
- TONGUE, RED
- Phenol in dermatology: updated evidence on efficacy and safety
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury
- Update on the Potential of <i>Punica granatum</i> L. Traditional Uses and Pharmacological Uses: A Review
- Skin Cyst: A Pathological Dead-End With a New Twist of Morphogenetic Potentials in Organoid Cultures
- Effect of Epipharyngeal Abrasive Therapy on Long COVID with Chronic Epipharyngitis
- Global Impact of Coronavirus Disease 2019 (COVID-19)
- Tertiary Lymphoid Organs at the Center Stage of Skin's Humoral Immunity
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Cordyceps militaris Grown on Germinated Rhynchosia nulubilis (GRC) Encapsulated in Chitosan Nanoparticle (GCN) Suppresses Particulate Matter (PM)-Induced Lung Inflammation in Mice
- Prolonged Drug-Induced Hypersensitivity Syndrome/DRESS With Alopecia Areata and Autoimmune Thyroiditis
- Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Comprehensive treatment of Cronkhite-Canada syndrome: A case report and literature review
- Cyclosporine-A-Induced Intracranial Thrombotic Complications: Systematic Review and Cases Report
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Alopecia Areata: An Updated Review for 2023
- A novel PLEC nonsense homozygous mutation (c.7159G > T; p.Glu2387*) causes epidermolysis bullosa simplex with muscular dystrophy and diffuse alopecia: a case report